Skip to main content
Top
Published in: Infection 3/2020

Open Access 01-06-2020 | Guillain-Barré Syndrome | Case Report

A horse and a zebra: an atypical clinical picture including Guillain-Barré syndrome, recurrent fever and mesenteric lymphadenopathy caused by two concomitant infections

Authors: Felix Amereller, Christian Lottspeich, Grete Buchholz, Karl Dichtl

Published in: Infection | Issue 3/2020

Login to get access

Abstract

Background

While Campylobacter jejuni represents the most common cause of bacterial gastroenteritis, Yersinia pseudotuberculosis infections are very rarely diagnosed in adults.

Case

We report on a previously healthy patient who presented several times at our hospital with fever, Guillain-Barré syndrome, recurrent abdominal symptoms and distinct mesenteric lymphadenopathy, respectively. This complicated and diagnostically challenging course of disease was caused by a C. jejuni and Y. pseudotuberculosis coinfection. Antibiotic treatment with doxycycline was effective.

Conclusion

Broad serology testing was crucial to discover that two concomitant infections were causing the symptoms. This case demonstrates that when a clinical picture is not fully explained by one known infection, another infection with the same underlying risk factor has to be considered, hence “a horse and a zebra”.
Appendix
Available only for authorised users
Literature
1.
go back to reference Horrocks SM, Anderson RC, Nisbet DJ, Ricke SC. Incidence and ecology of Campylobacter jejuni and coli in animals. Anaerobe. 2009;15:18–25.CrossRefPubMed Horrocks SM, Anderson RC, Nisbet DJ, Ricke SC. Incidence and ecology of Campylobacter jejuni and coli in animals. Anaerobe. 2009;15:18–25.CrossRefPubMed
2.
3.
go back to reference Nulens E, Decoster E-L, Schoonooghe M-C, Muyldermans A. An unexpected Campylobacter fetus infection. Infection. 2018;46:729–30.CrossRefPubMed Nulens E, Decoster E-L, Schoonooghe M-C, Muyldermans A. An unexpected Campylobacter fetus infection. Infection. 2018;46:729–30.CrossRefPubMed
4.
go back to reference Guzman-Herrador B, Vold L, Nygård K. Surveillance of travel-associated gastrointestinal infections in Norway, 2009–2010: are they all actually imported? Eurosurveillance. 2012;17:20294.PubMed Guzman-Herrador B, Vold L, Nygård K. Surveillance of travel-associated gastrointestinal infections in Norway, 2009–2010: are they all actually imported? Eurosurveillance. 2012;17:20294.PubMed
5.
go back to reference Blaser MJ. Epidemiologic and clinical features of Campylobacter jejuni Infections. J Infect Dis. 1997;176:103–5.CrossRef Blaser MJ. Epidemiologic and clinical features of Campylobacter jejuni Infections. J Infect Dis. 1997;176:103–5.CrossRef
6.
go back to reference Wachira VK, Peixoto HM, de Oliveira MRF. Systematic review of factors associated with the development of Guillain-Barré syndrome 2007–2017: what has changed? Trop Med Int Heal. 2019;24:132–42.CrossRef Wachira VK, Peixoto HM, de Oliveira MRF. Systematic review of factors associated with the development of Guillain-Barré syndrome 2007–2017: what has changed? Trop Med Int Heal. 2019;24:132–42.CrossRef
7.
go back to reference Rees JH, Soudain SE, Gregson NA, Hughes RAC. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med. 1995;333:1374–9.CrossRefPubMed Rees JH, Soudain SE, Gregson NA, Hughes RAC. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med. 1995;333:1374–9.CrossRefPubMed
8.
go back to reference Hauri AM, Just M, McFarland S, Schweigmann A, Schlez K, Krahn J. Campylobacteriosis outbreaks in the state of Hesse, Germany, 2005–2011: raw milk yet again. Dtsch Med Wochenschr. 2013;138:357–61.CrossRefPubMed Hauri AM, Just M, McFarland S, Schweigmann A, Schlez K, Krahn J. Campylobacteriosis outbreaks in the state of Hesse, Germany, 2005–2011: raw milk yet again. Dtsch Med Wochenschr. 2013;138:357–61.CrossRefPubMed
9.
go back to reference Kendall ME, Crim S, Fullerton K, Han PV, Cronquist AB, Shiferaw B, et al. Travel-associated enteric infections diagnosed after return to the United States, foodborne diseases active surveillance network (FoodNet), 2004–2009. Clin Infect Dis. 2012;54:S480–S487487.CrossRefPubMed Kendall ME, Crim S, Fullerton K, Han PV, Cronquist AB, Shiferaw B, et al. Travel-associated enteric infections diagnosed after return to the United States, foodborne diseases active surveillance network (FoodNet), 2004–2009. Clin Infect Dis. 2012;54:S480–S487487.CrossRefPubMed
10.
go back to reference Nuorti JP, Niskanen T, Hallanvuo S, Mikkola J, Kela E, Hatakka M, et al. A widespread outbreak of Yersinia pseudotuberculosis O:3 infection from iceberg lettuce. J Infect Dis. 2004;189:766–74.CrossRefPubMed Nuorti JP, Niskanen T, Hallanvuo S, Mikkola J, Kela E, Hatakka M, et al. A widespread outbreak of Yersinia pseudotuberculosis O:3 infection from iceberg lettuce. J Infect Dis. 2004;189:766–74.CrossRefPubMed
11.
go back to reference Long C, Jones TF, Vugia DJ, Scheftel J, Strockbine N, Ryan P, et al. Yersinia pseudotuberculosis and Y. enterocolitica infections, FoodNet, 1996–2007. Emerg Infect Dis. 2010;16:566–7.CrossRefPubMedPubMedCentral Long C, Jones TF, Vugia DJ, Scheftel J, Strockbine N, Ryan P, et al. Yersinia pseudotuberculosis and Y. enterocolitica infections, FoodNet, 1996–2007. Emerg Infect Dis. 2010;16:566–7.CrossRefPubMedPubMedCentral
12.
go back to reference Robert-Koch-Institut. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2018. Berlin: Robert-Koch-Institut; 2019. Robert-Koch-Institut. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2018. Berlin: Robert-Koch-Institut; 2019.
14.
go back to reference Tauxe RV. Salad and pseudoappendicitis: Yersinia pseudotuberculosis as a foodborne pathogen. J Infect Dis. 2004;189:761–3.CrossRefPubMed Tauxe RV. Salad and pseudoappendicitis: Yersinia pseudotuberculosis as a foodborne pathogen. J Infect Dis. 2004;189:761–3.CrossRefPubMed
15.
go back to reference Fukushima H, Matsuda Y, Seki R, Tsubokura M, Takeda N, Shubin FN, et al. Geographical heterogeneity between Far Eastern and western countries in prevalence of the virulence plasmid, the superantigen Yersinia pseudotuberculosis-derived mitogen, and the high-pathogenicity island among Yersinia pseudotuberculosis strains. J Clin Microbiol. 2001;39:3541–7.CrossRefPubMedPubMedCentral Fukushima H, Matsuda Y, Seki R, Tsubokura M, Takeda N, Shubin FN, et al. Geographical heterogeneity between Far Eastern and western countries in prevalence of the virulence plasmid, the superantigen Yersinia pseudotuberculosis-derived mitogen, and the high-pathogenicity island among Yersinia pseudotuberculosis strains. J Clin Microbiol. 2001;39:3541–7.CrossRefPubMedPubMedCentral
16.
go back to reference Fleming D, Hunt D. Biological safety: principles and practices. 4th ed. Washington, D.C.: American Society of Microbiology; 2006.CrossRef Fleming D, Hunt D. Biological safety: principles and practices. 4th ed. Washington, D.C.: American Society of Microbiology; 2006.CrossRef
17.
go back to reference Nathues C, Grüning P, Fruth A, Verspohl J, Blaha T, Kreienbrock L, et al. Campylobacter spp., Yersinia enterocolitica, and Salmonella enterica and their simultaneous occurrence in German fattening pig herds and their environment. J Food Prot. 2013;76:1704–11.CrossRefPubMed Nathues C, Grüning P, Fruth A, Verspohl J, Blaha T, Kreienbrock L, et al. Campylobacter spp., Yersinia enterocolitica, and Salmonella enterica and their simultaneous occurrence in German fattening pig herds and their environment. J Food Prot. 2013;76:1704–11.CrossRefPubMed
18.
go back to reference Tertti R, Granfors K, Lehtonen O-P, Mertsola J, Makela A-L, Valimaki I, et al. An outbreak of Yersinia pseudotuberculosis infection. J Infect Dis. 1984;149:245–50.CrossRefPubMed Tertti R, Granfors K, Lehtonen O-P, Mertsola J, Makela A-L, Valimaki I, et al. An outbreak of Yersinia pseudotuberculosis infection. J Infect Dis. 1984;149:245–50.CrossRefPubMed
19.
go back to reference Logsdon LK, Mecsas J. Requirement of the Yersinia pseudotuberculosis effectors YopH and YopE in colonization and persistence in intestinal and lymph tissues. Infect Immun. 2003;71:4595–607.CrossRefPubMedPubMedCentral Logsdon LK, Mecsas J. Requirement of the Yersinia pseudotuberculosis effectors YopH and YopE in colonization and persistence in intestinal and lymph tissues. Infect Immun. 2003;71:4595–607.CrossRefPubMedPubMedCentral
20.
go back to reference Attwood SEA, Cafferkey M, West AB, Healy E, Mealy K, Buckley TF, et al. Yersinia infection and acute abdominal pain. Lancet. 1987;329:529–33.CrossRef Attwood SEA, Cafferkey M, West AB, Healy E, Mealy K, Buckley TF, et al. Yersinia infection and acute abdominal pain. Lancet. 1987;329:529–33.CrossRef
Metadata
Title
A horse and a zebra: an atypical clinical picture including Guillain-Barré syndrome, recurrent fever and mesenteric lymphadenopathy caused by two concomitant infections
Authors
Felix Amereller
Christian Lottspeich
Grete Buchholz
Karl Dichtl
Publication date
01-06-2020
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 3/2020
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-020-01397-5

Other articles of this Issue 3/2020

Infection 3/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.